Price Targets
📊 Target Price Analysis:
Integrating the reports:
- Fundamentals: The fundamentals report gave a reasonable value range of $44-$66, with a target of $55, based on a P/S of 5.
- News Impact: The news analysis predicts an immediate-term downward move of -8% to -15% from pre-news levels. The stock was already struggling at ~$110 resistance. A 10% decline from $110 targets ~$99.
- Sentiment & Technicals: Sentiment is sharply negative. Technically, key support is at $100 (psych/20-DMA), then $88-$92 (previous consolidation/60-DMA). The chip distribution shows the average cost at $104.37; a break below this could accelerate selling.
Comprehensive Target Price Range:
- 1-Month Target (Conservative/Pessimistic): $85 - $95. This factors in the full negative news impact driving a break below the $100 support and testing the lower consolidation band. The bearish fundamentals support this move.
- 3-Month Target (Baseline): $70 - $85. This assumes the legal overhang and competitive concerns persist, compressing the valuation multiple further toward the fundamental model’s range. The stock digests the news in a lower trading range.
- 6-Month Target (Optimistic/Recovery Scenario): $55 - $75. This is not a bullish target. It represents a potential stabilization if the lawsuit is resolved favorably and no further client losses occur. The upper end of this range ($75) is still ~30% below the current price, aligning with the fundamental target’s upper bound. The lower end ($55) hits the fundamental report’s 12-month target sooner.
Specific Price Targets:
- Near-term (1-2 weeks): $92 (Test of strong technical support)
- 3-month: $77 (Midpoint of baseline range, aligning with a P/S de-rating)
- 6-month: $65 (Midpoint of recovery range, reflecting ongoing challenges)